WELKOM,   Inloggen   |   Registreren Trivano op Facebook Trivano op Twitter Volg Trivano via RSS  
Grafiek CrucellCrucell

CRXL | NL0000358562
Euronext Amsterdam
0,000 EUR   (-100,00%)
Beleg goedkoper met Lynx
Kosten order 3.000 EUR: 6,00 EUR
Toevoegen aan Mijn Selectie   Aandeel toevoegen aan Mijn selectie
Samenvatting Profiel Dividend Kerncijfers Insiders Nieuws Persberichten Agenda Grafiek Koersen

Crucell Intends to Delist Ordinary Shares on NYSE Euronext

Nieuws via RSS voor Crucell
15 maart 2011

 Dutch biopharmaceutical company Crucell N.V. (NYSE Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today announced that it has obtained the approval of Euronext Amsterdam N.V. to terminate the listing of its ordinary shares (Ordinary Shares) on NYSE Euronext in Amsterdam (NYSE Euronext).

The termination of the listing of Ordinary Shares on NYSE Euronext was approved by Euronext Amsterdam N.V. and will occur on 12 April 2011. The last trading day will be 11 April 2011.

As of the time of delisting from NYSE Euronext, the following codes will no longer be applicable to Crucell N.V. (Crucell): symbol “CRXL”: Euronext code NL0000358562, ISIN: NL0000358562.
 
Crucell intends to delist the Ordinary Shares from the Swiss Exchange (SIX) simultaneously with the delisting from NYSE Euronext.
 
As previously announced on 8 March 2011, to effect the delisting of the American Depositary Shares (ADSs) from the NASDAQ Global Market Select (NASDAQ), Crucell intends to file a Form 25 with the U.S. Securities and Exchange
Commission (SEC). Crucell intends to file a Form 15F with the SEC to deregister and terminate its reporting obligations under the U.S. Securities Exchange Act of 1934, as amended. The filing of the Form 15F will precede the delisting of the Ordinary Shares from NYSE Euronext and SIX.
 
Crucell reserves the right to delay or withdraw for any reason the filing of the Form 25 and Form 15F or the delisting on NYSE Euronext and/or SIX.


« Terug naar alle persberichten